Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Can Pan American Silver Maintain Its Solid Silver Production Rally?Photo, wide shot, wide-angle lens,  Coal mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/25526de2-54da-40ae-ba56-1e25dead3e81.png
Can Pan American Silver Maintain Its Solid Silver Production Rally?

Pan American Silver Corp. PAAS has delivered solid performance in 2025, backed by strong production growth and silver prices. The company produced 22.8 million ounces of silver in 2025, surpassing

Implied Volatility Surging for Abacus Global Management Stock Options
Implied Volatility Surging for Abacus Global Management Stock Options

Investors in Abacus Global Management, Inc. ABX need to pay close attention to the stock based on moves in the options market lately. That is because the April 17, 2026 $5.00 Call had some of the

ASH Introduces Pricing Actions to Manage Market Volatility
ASH Introduces Pricing Actions to Manage Market Volatility

Ashland Inc. ASH has announced an implantation of a series of pricing actions across Life Sciences, Intermediates, Personal Care and Specialty Additives product portfolios. This is in response to

Coca-Cola vs. Keurig: Which Beverage Stock Looks Poised for Growth?Photo, wide shot, wide-angle lens,  Restaurant, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/57273392-070f-46de-9297-125616327242.png
Coca-Cola vs. Keurig: Which Beverage Stock Looks Poised for Growth?

The rivalry between The Coca-Cola Company KO and Keurig Dr Pepper Inc. KDP highlights two powerful yet distinct approaches to beverage leadership. Coca-Cola dominates the global non-alcoholic

ALAB Benefits From Strong AI Infrastructure Demand: What's Ahead?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/012f8213-0bd1-4831-98f2-6d5fae956d6a.png
ALAB Benefits From Strong AI Infrastructure Demand: What's Ahead?

Astera Labs ALAB is benefiting from the growing demands of AI infrastructure, driven by increasing investments from major hyperscalers like Google and AWS, which have collectively projected nearly

Dave vs. UiPath: Which Disruptive Tech Stock Has an Upside?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.theapi.app/temp/32e7a10f-efd0-424a-861f-2f3e0bb7ce02.png
Dave vs. UiPath: Which Disruptive Tech Stock Has an Upside?

Both Dave Inc. DAVE and UiPath, Inc. PATH are disruptive, software-backed platforms utilizing technology to challenge traditional industries. While Dave addresses the digital-first banking in the

Labor Costs Move Higher
Labor Costs Move Higher

After a nice trading day basking in the green, following President Trump’s assertion that peace talks are going “very well” with Iran (while lacking particulars, and that’s putting it kindly)

EQNR Expands Brazil Footprint With Esquina do Vento Wind Project
EQNR Expands Brazil Footprint With Esquina do Vento Wind Project

Equinor ASA EQNR has acquired the 230 MW Esquina do Vento onshore wind project in Brazil from Vestas. Following the acquisition, EQNR expanded its onshore renewable energy portfolio, while enhancing

BASF's Aseptrol Business to be Acquired by Oxidium Technologies
BASF's Aseptrol Business to be Acquired by Oxidium Technologies

BASF SE BASFY recently entered into an agreement with Oxidium Technologies LLC to sell its Aseptrol technology portfolio, marking a strategic step in sharpening its focus by supporting growth in

AU's Free Cash Flow Triples in FY25: Can the Momentum Sustain?
AU's Free Cash Flow Triples in FY25: Can the Momentum Sustain?

AngloGold Ashanti plc AU delivered a record $2.9 billion in free cash flow in 2025, a whopping 204% year-over-year rise. The upside is driven by AngloGold Ashanti’s continued cost discipline, higher

Coca-Cola Faces Margin Pressure: Can Pricing Power Hold?
Coca-Cola Faces Margin Pressure: Can Pricing Power Hold?

The Coca-Cola Company KO shows resilience in its pricing strategy, but rising cost pressures and softer consumer conditions could test margins in 2026. Management highlighted that fourth-quarter

FDA Grants Priority Tag to Ionis' NDA for Alexander Disease DrugPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
FDA Grants Priority Tag to Ionis' NDA for Alexander Disease Drug

Ionis Pharmaceuticals IONS announced that the FDA has granted priority review to its new drug application (NDA) seeking approval for zilganersen for the treatment of patients with Alexander disease

DB to Exit India Retail Unit in Strategic Pivot to Core OperationsPhoto, wide shot, wide-angle lens,  Home appliance manufacturer, neutral atmosphere, photo by Joe Cornish: https://img.theapi.app/temp/fb3845ac-e3c6-43ef-86c1-b57ed8c272c4.png
DB to Exit India Retail Unit in Strategic Pivot to Core Operations

Deutsche Bank AG’s DB India retail business is set to be acquired by Kotak Mahindra Bank in a deal estimated at $480.3 million, according to a Reuters article published on MSN.

The reported deal

KTCC Nears 52-Week High: Can Operational Reset Drive Upside?
KTCC Nears 52-Week High: Can Operational Reset Drive Upside?

Key Tronic Corporation KTCC is closing in on its 52-week high of $2.73, finishing the most recent session at $2.72.

As KTCC approaches a key technical level, investors are increasingly evaluating

Signet Boosts Engagement Through Digital & Store Investments
Signet Boosts Engagement Through Digital & Store Investments

Signet Jewelers Limited SIG is advancing its “Grow Brand Love” strategy by shifting to a brand-led structure and concentrating on its largest banners while simplifying the broader portfolio. The

ASML vs. AMKR: Which Semiconductor Equipment Stock Has an Edge Now?Photo, wide shot, wide-angle lens,  Artificial intelligence developer, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/ee32e77c-b7d6-424b-91ea-4023f2292688.png
ASML vs. AMKR: Which Semiconductor Equipment Stock Has an Edge Now?

ASML Holding ASML and Amkor Technology AMKR are two key players in the AI infrastructure value chain serving widely different but crucial roles. While ASML specializes in lithography-based chip

Top Analyst Reports for Eli Lilly, RTX & Abbott
Top Analyst Reports for Eli Lilly, RTX & Abbott

Monday, March 23, 2026The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and

Citigroup vs. PNC Financial: Which Stock Is a Better Buy Now?Photo, wide shot, wide-angle lens,  Bank, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/094456a7-d529-4ef2-b536-c031f2afd618.png
Citigroup vs. PNC Financial: Which Stock Is a Better Buy Now?

Citigroup, Inc. C and The PNC Financial Services Group PNC represent two distinct approaches to banking within the U.S. financial sector, giving investors an interesting choice between global scale

Does URBN's Multi-Brand Strategy Position It for Long-Term Success?
Does URBN's Multi-Brand Strategy Position It for Long-Term Success?

Urban Outfitters Inc. URBN continues to demonstrate formidable brand strength, driven by a diversified portfolio that resonates across multiple customer segments. The company’s ability to deliver

Canterbury Park vs. High Roller: Which Casino Stock Is the Better Buy?
Canterbury Park vs. High Roller: Which Casino Stock Is the Better Buy?

In the gaming sector, Canterbury Park Holding Corporation CPHC and High Roller Technologies, Inc. ROLR represent two distinctly different operating models. Over the past six, High Roller shares have

APPS' AGP Business Shows Double-Digit Growth: Is it Sustainable?
APPS' AGP Business Shows Double-Digit Growth: Is it Sustainable?

Digital Turbine’s APPS App Growth Platform (AGP) business is experiencing robust growth. The segment grew 19% year over year in the third quarter of fiscal 2026 to $52.6 million due to solid demand

LXRX Stock Up as NVO Initiates Phase I Study of Partnered Obesity DrugPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
LXRX Stock Up as NVO Initiates Phase I Study of Partnered Obesity Drug

Shares of Lexicon Pharmaceuticals LXRX gained 5.1% on Monday after the company announced that its partner, Novo Nordisk NVO, a dominant player in the obesity market, has initiated an early-stage

Do Options Traders Know Something About ACCO Brands Stock We Don't?
Do Options Traders Know Something About ACCO Brands Stock We Don't?

Investors in ACCO Brands Corporation ACCO need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $2.50 Call had some of the highest

FSM vs. RIO: Which Basic Materials Stock Is a Better Buy Currently?Photo, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
FSM vs. RIO: Which Basic Materials Stock Is a Better Buy Currently?

Fortuna Mining FSM and Rio Tinto Group RIO are two well-known players in the Zacks Basic Materials industry. Rio Tinto is benefiting from rising copper production, driven by strong operational

APGE Stock Up as Skin Disease Drug Shows Sustained 52-Week Efficacy
APGE Stock Up as Skin Disease Drug Shows Sustained 52-Week Efficacy

Shares of Apogee Therapeutics APGE surged 20% on Monday after the company announced positive 52-week maintenance data from Part A of a mid-stage study of zumilokibart (APG777), a potential